Keith S. Manchester, Director at Arbutus Biopharma Corp (ABUS), sold 8,846 shares at $3.69 ($33K) on 2024-08-14, disclosed to the SEC on 2024-08-16.
Open-market sale of $33k ABUS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ROIV | SELL | 2025-12-18 | $71.8M | — | Filing → |
| ROIV | SELL | 2025-11-21 | $29.8M | — | Filing → |
| ROIV | SELL | 2024-09-26 | $11.7M | — | Filing → |